Assenagon Asset Management
TFFP

Assenagon Asset Management’s TFF Pharmaceuticals, Inc. Common Stock TFFP Stock Holding History

Assenagon Asset Management’s Portfolio TFFP Stock Details TFFP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-901
Closed -$174K – 1590
2021
Q3 		$174K Sell
901
-751
-45% -$159K ﹤0.01% 1244
2021
Q2 		$397K Buy
+1,652
New +$453K ﹤0.01% 1068

Other funds holding TFFP

DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
PCM
Princeton Capital Management Red Bank, New Jersey $367M AUM 45.24% 1-Year Est. Return

Assenagon Asset Management's TFFP Position: Q4 2021 in Review

Assenagon Asset Management sold out of TFF Pharmaceuticals, Inc. Common Stock (TFFP) in Q4 2021, closing a stake of 901 shares — an estimated $174K sold.

Assenagon Asset Management first reported a position in TFFP in Q2 2021 and held it in 2 quarters. The position peaked at $397K in Q2 2021. 51 funds tracked by Wall St. Rank hold TFFP as of Q4 2021.

  • Assenagon Asset Management reported no remaining TFF Pharmaceuticals, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Assenagon Asset Management sold 901 TFF Pharmaceuticals, Inc. Common Stock shares in Q4 2021, an estimated $174K.
  • Assenagon Asset Management first reported a position in TFF Pharmaceuticals, Inc. Common Stock in Q2 2021 and held it in 2 quarters.
  • Assenagon Asset Management's TFF Pharmaceuticals, Inc. Common Stock position peaked at $397K in Q2 2021.
  • 51 funds tracked by Wall St. Rank held TFF Pharmaceuticals, Inc. Common Stock as of Q4 2021.

Based on Assenagon Asset Management's 13F filing for Q4 2021, filed 1 Feb 2022.